$0.514
In the last 1 year, Novo Nordisk A/s has given 82.6% return, outperforming this stock by 135.4%
0.0%
Downside
Day's Volatility :2.6%
Upside
2.6%
0.88%
Downside
52 Weeks Volatility :63.63%
Upside
63.31%
Period | Geovax Labs Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -6.55% | -3.0% | 0.0% |
6 Months | -21.53% | 0.5% | 0.0% |
1 Year | -52.84% | 6.3% | 6.3% |
3 Years | -58.88% | 22.1% | 17.3% |
Market Capitalization | 13.6M |
Book Value | $0.65 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -0.74 |
PEG Ratio | 0.0 |
Wall Street Target Price | 6.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -45.44% |
Return On Equity TTM | -85.79% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -100.0% |
Gross Profit TTM | 81.5K |
EBITDA | -19.7M |
Diluted Eps TTM | -0.74 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.83 |
EPS Estimate Next Year | -0.81 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | -0.15 |
What analysts predicted
Upside of 1067.32%
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Geovax Labs Inc | -15.34% | -21.53% | -52.84% | -58.88% | -58.88% |
![]() Moderna, Inc. | -11.43% | -29.94% | -12.65% | 45.99% | 455.32% |
![]() Regeneron Pharmaceuticals, Inc. | -1.44% | 1.41% | 19.47% | 47.01% | 108.75% |
![]() Novo Nordisk A/s | -3.29% | 15.05% | 82.56% | 161.96% | 290.64% |
![]() Seagen, Inc. | 2.56% | 4.47% | 55.05% | 8.41% | 161.4% |
![]() Vertex Pharmaceuticals Incorporated | -0.86% | 11.4% | 20.1% | 27.79% | 81.52% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Geovax Labs Inc | NA | NA | 0.0 | -0.83 | -0.86 | -0.45 | 0.0 | 0.65 |
![]() Moderna, Inc. | 34.94 | 34.94 | 0.0 | -3.66 | 0.07 | 0.01 | 0.0 | 44.49 |
![]() Regeneron Pharmaceuticals, Inc. | 22.08 | 22.08 | 9.01 | 41.82 | 0.19 | 0.1 | 0.0 | 225.94 |
![]() Novo Nordisk A/s | 43.05 | 43.05 | 2.03 | 1.64 | 0.82 | 0.22 | 0.01 | 2.52 |
![]() Seagen, Inc. | NA | NA | 18.53 | -3.52 | -0.26 | -0.13 | 0.0 | 13.96 |
![]() Vertex Pharmaceuticals Incorporated | 26.67 | 26.67 | 0.41 | 14.71 | 0.25 | 0.16 | 0.0 | 60.01 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Geovax Labs Inc | Buy | $13.6M | -58.88% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $38.2B | 455.32% | 34.94 | 11.33% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $90.6B | 108.75% | 22.08 | 33.93% |
![]() Novo Nordisk A/s | Buy | $412.6B | 290.64% | 43.05 | 33.4% |
![]() Seagen, Inc. | Hold | $39.8B | 161.4% | NA | -33.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $89.7B | 81.52% | 26.67 | 35.4% |
Vanguard Group Inc
BlackRock Inc
Geode Capital Management, LLC
State Street Corporation
Morgan Stanley - Brokerage Accounts
TWO SIGMA SECURITIES, LLC
geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic vaccines for chronic hepatitis b infections and cancers. our mva-vlp platform supports in vivo production of non-infectious vlps from the cells of the very person receiving the vaccine, mimicking a natural infection, and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. for more information, visit www.geovax.com.
Organization | Geovax Labs Inc |
Employees | 14 |
CEO | Mr. David Alan Dodd |
Industry | Biotechnology |
Direxion Daily Jr Gld Mnrs Bull 2x Etf
$0.51
+0.27%
Trxade Health Inc
$0.51
+0.27%
Inverse Cramer Tracker Etf
$0.51
+0.27%
Short Dow30 Proshares
$0.51
+0.27%
Bondbloxx Usd Hy Bond Cons Cyclicals Sctr Etf
$0.51
+0.27%
Cabana Target Drawdwn 10 Etf
$0.51
+0.27%
Westport Fuel Systems Inc
$0.51
+0.27%
Mgo Global Inc
$0.51
+0.27%
Indonesia Msci Etf Ishares
$0.51
+0.27%